Enero-Marzo 2017 69
ISSN 1317-987X
 
Buscar




Artículos
 




Enfermedad de Creutzfeldt-Jakob Esporádica en Venezuela: A propósito de un nuevo caso

Referencias

1. Bell JE, Ironside JW. Neuropathology of spongiform encephalophaties in humans. Br Med Bull, 1993; 49: 738-77.

2. Brown P, Bradley R. 1755 and all that: a historical primer of transmissible spongiform encephalopathy. BMJ 1998; 317: 1688-92.

3. Brown P, Gibbs CJ, Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994; 35: 513-29.

4. DeArmond SJ. Overview of the transmissible spongiform encephalophaties: prion protein disorders. Br Med Bull 1993; 49: 725-37.

5. DeArmond SJ, Prusiner SB. Etiology and pathogenesis of prion diseases. Am J Pathol 1995; 146: 785-811.

6. Haywood AM. Transmissible spongiform encephalophaties. N Engl J Med 1997; 337: 1821-8.

7. Head MW, Ironside JW. Review: Creutzfeldt–Jakob disease: prion protein type, disease phenotype and agent strain. Neuropathol Appl Neurobiol 2012; 38: 296-310.

8. Imran M, Mahmood S. An overview of human prion diseases. Virology Journal [revista en internet] 2011 [consultado 28 de diciembre de 2016]; 8: 559 [9 pantallas]. Disponible en: http://www.virologyj.com/content/8/1/559.

9. Ironside JW. Prion diseases in man. J Pathol 1998; 186: 227-34.

10. Lantos PL. From slow virus to prion: a review of transmissible spongiform encephalophaties. Histophatology 1992; 20: 1-11.

11. Prusiner SB, Hsiao KK. Human prion diseases. Ann Neurol 1994; 35: 385-95.

12. Prusiner SB. The prion diseases. Brain Pathol 1998; 8: 499-513.

13. Richardson EP, Masters CL. The nosology of Creutzfeldt-Jakob disease and conditions related to the accumulation of PrPCJD in the nervous system. Brain Pathol 1995; 5: 33-41.

14. van der Valk P. Prion diseases: what will be next?. J Clin Pathol 1998; 51: 265-9.

15. Wadsworth JDF, Collinge J. Update on human prion disease. Biochim Biophys Acta 2007; 1772 (6): 598-609.

16. Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of “new variant” CJD. Nature 1996; 383: 685-90.

17. Hernández A, Céspedes G, González J. Enfermedades priónicas en humanos. Gac Méd Caracas 2002; 110 (1): 9-18.

18. Prusiner SB. Molecular biology of prion disease. Science 1991; 252: 1515-22.

19. Tateishi J. Prion diseases. Microbiol Immunol 1995; 39: 923-8.

20. Brown P. The risk of bovine spongiform encephalopathy (“mad cow disease”) to human health. JAMA 1997; 278: 1008-11.

21. Brown P, Will RG, Bradley R, Asher DM, Detwiler L. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: background, evolution, and current concerns. Emerg Infect Dis [revista en internet] 2001 jan-feb [consultado 25 de febrero de 2001]; 7 (1): [13 pantallas]. Disponible en: http://www.cdc.gov/ncidoc/eid/vol7no1/brown.htm.

22. Hernández A, Céspedes G, Romero S. Encefalopatía espongiforme bovina o “enfermedad de las vacas locas”. Gac Méd Caracas 2002; 110 (2): 151-65.

23. Prusiner SB. Prion diseases and the BSE crisis. Science 1997; 278: 245-50.

24. Sánchez-Juan P, Cousens SN, Will RG, van Duijn CM. Source of variant Creutzfeldt-Jakob disease outside United Kingdom. Emerg Infect Dis 2007; 13 (8): 1166-9.

25. Brown P, Cathala F, Raubertas RF, Gajdusek DC, Castaigne P. The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature. Neurology 1987; 37: 895-904.

26. Will RG. Epidemiology of Creutzfeldt-Jakob disease. Br Med Bull 1993; 49: 960-70.

27. World Health Organization. Public health issues and clinical and neurological characteristics of the new variant of Creutzfeldt-Jakob disease and other human and animal transmissible spongiform encephalopathies: memorandum from two WHO meetings. Bull World Health Organ 1996; 74: 453-63.

28. Kretzchmar HA, Ironside JW, DeArmond SJ, Tateishi J. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol 1996; 53: 913-20.

29. Will R, Zeidler M. Diagnosing Creutzfeldt-Jakob disease [letter]. BMJ 1996; 313: 833-4.

30. Kenney K, Brechtel C, Takahashi H, Kurohara K, Anderson P, Gibbs CJ. An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patients. Ann Neurol 2000; 48: 395-8.

31. Lemstra AW, van Meegen MT, Vreyling JP, Meijerink PHS, Jansen GH, Bulk S, et al. 14-3-3 testing in diagnosing Creutzfeldt-Jakob disease. A prospective study in 112 patients. Neurology 2000; 55: 514-6.

32. Wiltfang J, Otto M, Baxter HC, Bodemer M, Steinacker P, Bahn E, et al. Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creuztfeldt-Jakob disease. J Neurochem 1999; 73: 2485-90.

33. Zeidler M. 14-3-3 cerebrospinal fluid protein and Creutzfeldt-Jakob disease [letter]. Ann Neurol 2000; 47: 683-4.

34. Atarashi R, Sano K, Satoh K, Nishida N. Real-time quaking-induced conversion. A highly sensitive assay for prion detection. Prion 2011; 5 (3): 150-3.

35. McGuire L, Peden A, Orrú C, Wilham J, Appleford N, Mallinson G, et al. RT-QuIC analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Ann Neurol 2012; 72 (2): 278-85.

36. Van Everbroeck B, Pals P, Dziedzic T, Dom R, Godfraind C, Sciot R, et al. Retrospective study of Creutzfeldt-Jakob disease in Belgium: neuropathological findings. Acta Neuropathol 2000; 99: 358-64.

37. Tateishi J, Kitamoto T. Developments in diagnosis for prion diseases. Br Med Bull 1993; 49: 971-9.

38. Yokoyama T. The immunodetection of the abnormal isoform of prion protein. Histochem J 1999; 31: 209-12.

39. Aguzzi A, Weissmann C. A suspicious signature. Nature 1996; 383: 666-7.

40. Castellani RJ, Parchi P, Madoff L, Gambetti P, McKeever P. Biopsy diagnosis of Creutzfeldt-Jakob disease by Western blot: a case report. Hum Pathol 1997; 28: 623-6.

41. Schulz-Schaeffer WJ, Tschöke S, Kranefuss N, Dröse W, Hause-Reitner D, Giese A, et al. The paraffin-embedded tissue blot detects PrPSc early in the incubation time in prion disease. Am J Pathol 2000; 156: 51-6.

42. Boussin F, Jaegly A, Deslys JP, Dormont D. A simple and rapid method for sequencing the entire coding region of the human prion protein (PrP) gene. J Neurosci Methods 1994; 54: 103-7.

43. Collinge J, Harding AE, Owen F, Poulter M, Lofthouse R, Boughey AM, et al. Diagnosis of Gerstmann-Sträussler syndrome in familial dementia with prion protein gene analysis. Lancet 1989; july 1: 15-7.

44. Petraroli R, Vaccari G, Pocchiari M. A rapid and efficient method for the detection of point mutations of the human prion protein gene (PRNP) by direct sequencing. J Neurosci Methods 2000; 99: 59-63.

45. Zimmermann K, Turecek PL, Schwarz HP. Genotyping of the prion protein gene at codon 129. Acta Neuropathol 1999; 97: 355-8.

46. Caraballo AJ. Creutzfeldt-Jakob disease in Venezuela: a case report. Arq Neuro-Psiquiat (Sâo Paulo) 1991; 49: 218-21.

47. Faoro A, Filomena MV, de Pernía E, Borges J. Importancia del EEG en el diagnóstico de la Enfermedad de Jakob-Creutzfeldt. A propósito de dos casos. Rev Ven Neurol Neurocir 1987; 1: 17-20.

48. Hernández A, Céspedes G, González A, Alvárez A, Lara C, Soto A, y col. Enfermedad de Creutzfeldt-Jakob en Venezuela: informe de 10 casos y revisión de la literatura. Rev Inst Nac Hig “Rafael Rangel” 1999; 30: 14-20.

49. Hernández A, Céspedes G, Larrea F, Querales J, Romero G, López N. Encefalopatías espongiformes transmisibles o enfermedades priónicas. Revisión general y casuística venezolana. Organización Panamericana de la Salud y Facultad de Medicina de la Universidad Central de Venezuela: Caracas, 2002.

50. Méndez O, Luzardo G, Molina O, Cardozo J. Enfermedad de Creutzfeldt-Jakob. Reporte de 2 casos. Invest Clín 1995; 36: 23-30.

51. Postalian K, Mariño C, López J, Amundaray G. Enfermedad de Creutzfeldt-Jakob: a propósito de un caso con proteína 14-3-3 y resonancia magnética por difusión pesada. Centro Médico 2004; 49 (2): 100-5.

52. Caruzo G, Díaz F, Bohórquez M, Rodríguez L, Gambetti P, Molina O, y col. Encefalopatía priónica familiar. En: XLIII Jornadas Venezolanas de Anatomía Patológica. San Cristobal: Sociedad Venezolana de Anatomía Patológica; 1999. p.17.

53. Hernández A, Céspedes G. Medidas de bioseguridad para el manejo clínico y de laboratorio de pacientes con enfermedades priónicas. Gac Méd Caracas 2002; 110 (3): 318-27.

54. Gambetti P, Kong Q, Zou W, Parchi P, Chen SG. Sporadic and familial CJD: classification and characterisation. Br Med Bull 2003; 66: 213-39.

55. Tateishi J, Kitamoto T. Inherited prion diseases and transmission to rodents. Brain Pathol 1995; 5: 53-9.

56. Gambetti P, Petersen R, Monari L, Tabaton M, Autilio-Gambetti L, Cortelli P, et al. Fatal familial insomnia and the widening spectrum of prion diseases. Br Med Bull 1993; 49: 980-94.

57. Ghetti B, Dlouhy SR, Giaccone G, Bugiani O, Frangione B, Farlow MR, et al. Gerstmann-Sträussler-Scheinker disease and the Indiana Kindred. Brain Pathol 1995; 5: 61-75.

58. Cervenáková L, Goldfarb LG, Garruto R, Lee H-S, Gajdusek DC, Brown P. Phenotype-genotype studies in kuru: implications for new variant Creutzfeldt-Jakob disease. Proc Natl Acad Sci USA 1998; 95: 13239-41.

59. McLean CA, Ironside JW, Alpers MP, Brown PW, Cervenáková L, Anderson RMcD, et al. Comparative neuropathology of Kuru with the new variant of Creutzfeldt-Jakob disease: evidence for strain if agent predominating over genotype of host. Brain Pathol 1998; 8: 429-37.

60. Aguzzi A, Zhu C. Five questions on prion diseases. PLoS Pathogens [revista en internet] 2012 [consultado 28 de diciembre de 2016]; 8 (5): [4 pantallas]. Disponible en: www.plospathogens.org.

61. Brown P, Preece M, Brandel J-P, Sato T, McShane L, Zerr I, et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000; 55: 1075-81.

62. Almond J, Pattison J. Human BSE. Nature 1997; 389: 437-8.

63. Ashraf H. BSE inquiry uncovers “a peculiarly British disaster”. Lancet 2000; 356: 1579-80.

64. Balter M. Tracking the human fallout from “mad cow disease”. Science 2000; 289: 1452-4.

65. Collee JG, Bradley R. BSE: a decade on-part 2. Lancet 1997; 349: 715-21.

66. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347: 921-5.

67. Will RG, Zeidler M, Stewart GE, Macleod MA, Ironside JW, Cousens SN, et al. Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol 2000; 47: 575-82.

68. Zeidler M, Johnstone EC, Bamber RWK, Dickens CM, Fisher CJ, Francis AF, et al. New variant Creutzfeldt-Jakob disease: psychiatric features. Lancet 1997; 350: 908-10.

69. Zeidler M, Stewart GE, Barraclough CR, Bateman DE, Bates D, Burn DJ, et al. New variant Creutzfeldt-Jakob disease: neurological features and diagnostic test. Lancet 1997; 350: 903-7.

70. Streichenberger N, Jordan D, Verejan I, Souchier C, Philippeau F, Gros E, et al. The first case of new variant Creutzfeldt-Jakob disease in France: clinical data and neuropathological findings. Acta Neuropathol 2000; 99: 704-8.

71. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, et al. Transmissions to mice indicate that “new variant” CJD is caused by BSE agent. Nature 1997; 389: 498-501.


Enfermedad de Creutzfeldt-Jakob Esporádica en Venezuela: A propósito de un nuevo caso
Introducción
Resumen clínico
Hallazgos neuropatológicos
Discusión
Referencias

NOTA: Toda la información que se brinda en este artículo es de carácter investigativo y con fines académicos y de actualización para estudiantes y profesionales de la salud. En ningún caso es de carácter general ni sustituye el asesoramiento de un médico. Ante cualquier duda que pueda tener sobre su estado de salud, consulte con su médico o especialista.





Instituto de Medicina Tropical - Facultad de Medicina - Universidad Central de Venezuela.
Elaborado por el Centro de Análisis de Imágenes Biomédicas Computarizadas CAIBCO,
caibco@ucv.ve
Este portal ha sido desarrollado gracias al apoyo del Fonacit